Skip to main content
. 2013 Mar 15;10(5):567–574. doi: 10.7150/ijms.5795

Table 3.

Patients with viral breakthrough.

ETV LAM
Adherence rate ≥90% <90% ≥90% <90%
Resistance mutation (+) 1 1 31 1
L180M 1 1 N.D. N.D.
T184A 1 0 N.D. N.D.
S202G 0 1 N.D. N.D.
M204V 1 1 9 1
M204I 0 0 17 0
M204V/I 0 0 5 0
M250V 0 0 N.D. N.D.
Resistance mutation (-) 1 1 0 2

ETV, entecavir; LAM, lamivudine; N.D., not determined. Numbers of amino acid positions were according to Refs. 2 and 10.